Two Sigma Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Two Sigma Securities’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,943	Closed	-$219K	–	3386
2024 Q3	$219K	Buy	+4,943	New	+$212K	﹤0.01%	2059
2019 Q2	–	Sell	-7,617	Closed	-$317K	–	2473
2019 Q1	$317K	Buy	7,617 +1,617	+27%	+$65.7K	﹤0.01%	1153
2018 Q4	$220K	Buy	+6,000	New	+$256K	﹤0.01%	1638
2018 Q2	–	Sell	-8,271	Closed	-$346K	–	3065
2018 Q1	$346K	Buy	8,271 +1,175	+17%	+$51.2K	﹤0.01%	1911
2017 Q4	$309K	Sell	7,096 -124,624	-95%	-$5.3M	0.01%	982
2017 Q3	$5.61M	Buy	131,720 +106,953	+432%	+$4.53M	0.51%	45
2017 Q2	$1.07M	Sell	24,767 -100,566	-80%	-$4.24M	0.2%	86
2017 Q1	$5.24M	Buy	125,333 +118,208	+1,659%	+$4.82M	1.03%	13
2016 Q4	$279K	Buy	+7,125	New	+$290K	0.09%	281

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Two Sigma Securities's XPH Position: Q4 2024 in Review

Two Sigma Securities sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2024, closing a stake of 4,943 shares — an estimated $219K sold.

Two Sigma Securities first reported a position in XPH in Q4 2016 and held it in 9 quarters. The position peaked at $5.61M in Q3 2017. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2024.

Two Sigma Securities reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2024 after selling out during the quarter.
Two Sigma Securities sold 4,943 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2024, an estimated $219K.
Two Sigma Securities first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2016 and held it in 9 quarters.
Two Sigma Securities's State Street SPDR S&P Pharmaceuticals ETF position peaked at $5.61M in Q3 2017.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.